ArticleEndocrine2022

Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question.

Irene Caramella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.